Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Custom Truck One Source | CTOS | Apr 17, 2025 | 3.80 | +12.09 |
Customers Bancorp | CUBI | Apr 17, 2025 | 45.52 | +0.93 |
Customers Bancorp E Pref | CUBI-E | Apr 17, 2025 | 25.43 | +0.39 |
Customers Bancorp F Pref | CUBI-F | Apr 17, 2025 | 25.27 | +0.36 |
CVB Financial | CVBF | Apr 17, 2025 | 17.70 | +1.32 |
CVD Equipment | CVV | Apr 17, 2025 | 3.07 | -0.97 |
CVR Energy | CVI | Apr 17, 2025 | 18.39 | +2.39 |
Cvr Partners LP Unit | UAN | Apr 17, 2025 | 74.44 | +1.97 |
CVRx | CVRX | Apr 17, 2025 | 6.25 | +1.63 |
CVS Health | CVS | Apr 17, 2025 | 67.29 | -1.84 |
CXApp A | CXAI | Apr 17, 2025 | 1.10 | +2.80 |
CyberArk Software | CYBR | Apr 17, 2025 | 325.84 | -1.65 |
Cybin | CYBN | Apr 17, 2025 | 7.35 | -1.34 |
Cyclacel Pharmaceuticals | CYCC | Apr 17, 2025 | 0.23 | +4.48 |
Cyclacel Pharmaceuticals Pref | CYCCP | Apr 17, 2025 | 4.59 | +9.03 |
Cyclerion Therapeutics | CYCN | Apr 17, 2025 | 2.75 | +2.61 |
Cyclo Therapeutics | CYTH | Apr 17, 2025 | 0.72 | 0.00 |
Cycurion | CYCU | Apr 17, 2025 | 0.43 | 0.00 |
Cyngn | CYN | Apr 17, 2025 | 4.51 | +1.01 |
Cytek Biosciences | CTKB | Apr 17, 2025 | 3.65 | -0.55 |
Cytokinetics | CYTK | Apr 17, 2025 | 39.48 | +0.84 |
Cytomed Therapeutics | GDTC | Apr 17, 2025 | 2.46 | +5.58 |
CytomX Therapeutics | CTMX | Apr 17, 2025 | 0.66 | +4.18 |
Cytosorbents | CTSO | Apr 17, 2025 | 1.03 | +0.98 |
D-MARKET Electronic Services & Trading ADR | HEPS | Apr 17, 2025 | 2.89 | +2.85 |
D-Wave Quantum | QBTS | Apr 17, 2025 | 6.42 | -0.31 |
D.R. Horton | DHI | Apr 17, 2025 | 121.25 | +3.16 |
Dada Nexus ADR | DADA | Apr 17, 2025 | 1.85 | 0.00 |
Daily Journal | DJCO | Apr 17, 2025 | 377.40 | -1.20 |
Dakota Gold | DC | Apr 17, 2025 | 2.82 | -2.08 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.